| Literature DB >> 26757035 |
Gianfranco Spalletta1, Luca Cravello1, Walter Gianni2, Federica Piras1, Mariangela Iorio1, Claudia Cacciari1, Anna Rosa Casini3, Chiara Chiapponi1, Giuseppe Sancesario4, Claudia Fratangeli1, Maria Donata Orfei1, Carlo Caltagirone1,4, Fabrizio Piras1,5.
Abstract
Homotaurine supplementation may have a positive effect on early Alzheimer's disease. Here, we investigated its potential neuroprotective effect on the hippocampus structure and episodic memory performances in amnestic mild cognitive impairment (aMCI). Neuropsychological, clinical, and neuroimaging assessment in 11 treated and 22 untreated patients were performed at baseline and after 1 year. Magnetic resonance data were analyzed using voxel-based morphometry to explore significant differences (Family Wise Error corrected) between the two groups over time. Patients treated with homotaurine showed decreased volume loss in the left and right hippocampal tail, left and right fusiform gyrus, and right inferior temporal cortex which was associated with improved short-term episodic memory performance as measured by the recency effect of the Rey 15-word list learning test immediate recall. Thus, homotaurine supplementation in individuals with aMCI has a positive effect on hippocampus atrophy and episodic memory loss. Future studies should further clarify the mechanisms of its effects on brain morphometry.Entities:
Keywords: Amnestic mild cognitive impairment; episodic memory; hippocampus; homotaurine; structural magnetic resonance imaging; tramiprosate
Mesh:
Substances:
Year: 2016 PMID: 26757035 DOI: 10.3233/JAD-150484
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472